On Friday, FuelCell Energy Inc (NASDAQ:FCEL)’s shares declined -2.38% to $1.23.
FuelCell Energy Inc (FCEL) declared a projected 63.3 megawatt fuel cell park in Beacon Falls, Connecticut. The project, known as the Beacon Falls Energy Park, will be the world’s largest, if built as designed. The project was recently presented to Beacon Falls officials during a special meeting by O&G Industries and CT Energy & Technology. Under a letter of intent, FuelCell Energy has been identified as the fuel cell supplier, and if the park becomes operational, is predictable to be retained to operate and maintain the plants under a long term service agreement. O&G Industries owns the property.
CT Energy & Technology is developing and will own the project. The electric grid interconnection study is in process with ISO New England and site engineering is in advanced stages. Next steps are to finalize the off-taker of the power and prepare contracts.
FuelCell Energy, Inc., together its auxiliaries, designs, manufactures, sells, installs, operates, and services stationary fuel cell power plants for distributed power generation. The company is also involved in the development, design, production, and sale of fuel cell products under the Direct FuelCell name. Its power plants electrochemically produce electricity and heat using various fuels, counting natural gas, methanol, diesel, biogas, coal gas, coal mine methane, and propane.
Cempra Inc (NASDAQ:CEMP)’s shares dropped -2.37% to $34.14.
Cempra Inc (CEMP) stated financial results for the quarter ended March 31, 2015 and offered an update on recent corporate developments. The company will host a webcast and conference call recently at 4:30 p.m. EDT.
First Quarter 2015 and Recent Corporate Highlights
- In April 2015, investigators presented abstracts and select data from clinical and scientific studies of solithromycin at the European Congress of Clinical Microbiology (ECCMID) in Copenhagen, Denmark. Two studies with Taksta(TM) (fusidic acid) were also presented. Additionally, Cempra made a presentation on solithromycin at the 2015 Pediatric Academic Societies (PAS) Annual Meeting in San Diego. This pediatric study was funded by BARDA (Biomedical Advanced Research Development Authority).
Cempra, Inc., a clinical-stage pharmaceutical company, focuses on developing antibiotics to meet medical needs in the treatment of bacterial infectious diseases in North America. Its lead product candidates comprise solithromycin (CEM-101), which is in Phase III clinical trials for the treatment of community attained bacterial pneumonia, in addition to for uncomplicated bacterial urethritis; and Taksta (CEM-102), an antibiotic that has accomplished Phase II clinical trials for refractory bone and joint infections.
At the end of Friday’s trade, Castlight Health Inc (NYSE:CSLT)‘s shares dipped -2.19% to $8.49.
Castlight Health Inc (CSLT) declared that Viacom Inc. has selected the Castlight Enterprise Healthcare Cloud to provide resources to employees that will assist them make the most of their benefits and enable more informed healthcare decisions.
The Castlight Enterprise Healthcare Cloud is designed to simplify the healthcare benefits experience for employees, providing a ‘one-stop shop’ that comprises detailed information about care options. In addition, the platform assists companies understand the health needs of their employee population through predictive insights rather than relying on retrospective analysis of past care.
Castlight Health, Inc. provides cloud-based software in the United States. Its software enables enterprises to understand and manage health care spending. It offers Enterprise Healthcare Cloud that transforms external and internal complex data into transparent and useful information.
Magnum Hunter Resources Corp (NYSE:MHR), ended its Friday’s trading session with -2.17% loss, and closed at $1.80.
Magnum Hunter Resources Corp (MHR) declared recently financial and operating results for the three months ended March 31, 2015. The Company plans to file its Form 10-Q for the quarter ended March 31, 2015 with the Securities and Exchange Commission later recently, Monday, May 11, 2015. Highlights of the Company’s financial and operating results comprise the following:
- Proved reserves raised 73% in first quarter 2015 to 869.2 Bcfe (75% natural gas)
- Stated production of 163.6 MMcfe/d (27,261 Boe/d) for first quarter 2015, a 66% enhance over the preceding year comparable quarter
- First quarter 2015 production mix of 74% natural gas, 13% NGLs and 13% oil
- Average realized natural gas price for first quarter 2015 was $2.91 per Mcf (a $0.04 positive differential to the average NYMEX price for the period)
- Recent record throughput volumes on Eureka Hunter Pipeline System of about 623,713 MMBtu/d
- Production costs per Mcfe for first quarter 2015 declined 36% to $0.94, contrast to the preceding year comparable quarter
- Adjusted EBITDAX(a)for first quarter 2015 was $13.4 million
Magnum Hunter Resources Corporation, an independent oil and gas company, explores for, exploits, acquires, develops, and produces crude oil, natural gas, and natural gas liquid resources in the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
